Search
for
Sort by
Research 61–90 of 818
- Clinical and sociodemographic features of alopecia areata in five Colombian cities: an analysis of the RENAAC registry
- Eyelashes: Anatomical and Physiological Features, Eyelash Loss and Trichomegaly: Review
- Knowledge and beliefs about the use/abuse of oral contraceptive pills among males: A mixed-method explanatory sequential study in community pharmacy settings
- The rationale for physiological testosterone replacement in women
- Pregnancy and the Skin
- Cutaneous Markers of Disorders Affecting Adult Horses
- The frequency of polycystic ovary syndrome in women with prediabetes compared with normoglycemic women
- Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial
- Gut–ovary axis and multiomic insights into PCOS in a DHEA-induced rat model
- Pharmacokinetic and Therapeutic Dose Comparison of Diane-35 and IVF-C Inj 5000 IU in Common Quail
- Bicalutamide does not raise transaminases in comparison to alternative anti-androgen regimens among transfeminine adolescents and young adults: a retrospective cohort study
- Metabolic Aspects of Polycystic Ovary Syndrome
- A Clinical Approach to Severe Insulin Resistance
- Hot Flashes in a Young Girl: A Wake-up Call Concerning Serenoa repens Use in Children
- Polycystic ovary syndrome: diagnosis and management of related infertility
- Clinical efficacy of Tryushana Churna in management of Hypothyroidism
- EFFECTS OF HORMONAL THERAPY IN TRANSGENDERS
- Diagnosis, Management, and Associated Comorbidities of Polycystic Ovary Syndrome: A Narrative Review
- Cross‐Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short‐Time Follow‐Up: Results from the European Network for the Investigation of Gender Incongruence
- Androgens in women
- Antiandrogen therapy with spironolactone for the treatment of hidradenitis suppurativa
- Effects of two estroprogestins containing ethynilestradiol 30mug and drospirenone 3 mg and ethynilestradiol 30mug and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations
- Are Women with Polycystic Ovary Syndrome at Increased Risk of Alzheimer Disease? Lessons from Insulin Resistance, Tryptophan and Gonadotropin Disturbances and Their Link with Amyloid-Beta Aggregation
- Dermatologic manifestations in patients of renal disease on hemodialysis
- Peripubertal Testosterone, 17β-Estradiol and Progesterone Concentrations in Hair and Nails in Dobermann Dogs
- Dermatoses of pregnancy
- Estrus, ovulation, and serum progesterone, estradiol, and LH concentrations in mares after an increased photoperiod during winter.
- Estrus, Ovulation, and Serum Progesterone, Estradiol, and LH Concentrations in Mares After an Increased Photoperiod During Winter
- An Update on Polycystic Ovary Syndrome
- Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder?